COST-EFFECTIVENESS ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE

被引：0
|
作者：
Belousov, D. [1 ]
Afanasieva, E. [2 ]
机构：
[1] Ctr Pharmacoecon Res LLC, Moscow, Russia
[2] LLC Ctr Pharmacoecon Res, Moscow, Russia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2466
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND51
引用
收藏
页码：A757 / A757
页数：1
相关论文
共 50 条
  • [41] Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis
    Fundament, Tomasz
    Eldridge, Paul R.
    Green, Alexander L.
    Whone, Alan L.
    Taylor, Rod S.
    Williams, Adrian C.
    Schuepbach, W. M. Michael
    PLOS ONE, 2016, 11 (07):
  • [42] Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson's Disease
    Frampton, James E.
    DRUGS, 2014, 74 (18) : 2175 - 2190
  • [43] Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease
    James E. Frampton
    Drugs, 2014, 74 : 2175 - 2190
  • [44] The effectiveness of pramipexole in early and advanced Parkinson's disease and comparison of the results with ropinirole
    Karakaya, F.
    Ozturk, S.
    Ceviz, I.
    Kusbeci, O. Yilmaz
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 668 - 668
  • [45] Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan
    Shimbo, T
    Hira, K
    Takemura, M
    Fukui, T
    PHARMACOECONOMICS, 2001, 19 (08) : 875 - 886
  • [46] COST-EFFECTIVENESS ANALYSIS OF IPX066 IN ADVANCED PARKINSON'S DISEASE
    Arnold, R. J.
    Frasco, M. A.
    Layton, A.
    Rustay, N. R.
    Chen, S.
    VALUE IN HEALTH, 2015, 18 (03) : S283 - S283
  • [47] Evaluating the cost-effectiveness of an early detection of Parkinson's disease through innovative technology
    Munoz, David A.
    Kilinc, Mehmet Serdar
    Nembhard, Harriet B.
    Tucker, Conrad
    Huang, Xuemei
    ENGINEERING ECONOMIST, 2017, 62 (02): : 180 - 196
  • [48] Deep brain stimulation in the treatment of Parkinson's disease - A cost-effectiveness analysis
    Tomaszewski, KJ
    Holloway, RG
    NEUROLOGY, 2001, 57 (04) : 663 - 671
  • [49] Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson’s Disease in Japan
    Takuro Shimbo
    Kenji Hira
    Manabu Takemura
    Tsuguya Fukui
    PharmacoEconomics, 2001, 19 : 875 - 886
  • [50] Long term pramipexole monotherapy in patients with tremor-dominant early Parkinson's disease
    Takahashi, H.
    Yoshii, F.
    Fujimoto, K.
    Kawakami, T.
    Hishida, R.
    Chiba, H.
    Takagi, S.
    MOVEMENT DISORDERS, 2009, 24 : S282 - S282
12345